Matches in SemOpenAlex for { <https://semopenalex.org/work/W2054303973> ?p ?o ?g. }
- W2054303973 endingPage "428" @default.
- W2054303973 startingPage "428" @default.
- W2054303973 abstract "IMPORTANCE Establishing the natural history of G11778A Leber hereditary optic neuropathy (LHON) is important to determine the optimal end points to assess the safety and efficacy of a planned gene therapy trial. OBJECTIVE To use the results of the present natural history study of patients with G11778A LHON to plan a gene therapy clinical trial that will use allotopic expression by delivering a normal nuclear-encoded ND4 gene into the nuclei of retinal ganglion cells via an adeno-associated virus vector injected into the vitreous. DESIGN, SETTING, AND PARTICIPANTS A prospective observational study initiated in 2008 was conducted in primary and referral institutional practice settings. Participants included 44 individuals with G11778A LHON, recruited between September 2008 and March 2012, who were evaluated every 6 months and returned for 1 or more follow-up visits (6-36 months) as of August 2012. EXPOSURES Complete neuro-ophthalmic examination and main measures. MAIN OUTCOMES AND MEASURES Visual acuity, automated visual field testing, pattern electroretinogram, and spectral-domain optical coherence tomography. RESULTS Clinical measures were stable during the follow-up period, and visual acuity was as good as or better than the other visual factors used for monitoring patients. Based on a criterion of 15 or more letters from the Early Treatment Diabetic Retinopathy Study chart, 13 eyes of 8 patients (18%) improved, but 24 months after the onset of symptoms, any further improvements were to no better than 20/100. Acuity recovery occurred in some patients despite continued marked retinal nerve fiber layer thinning indistinguishable from that in patients who did not recover visual acuity. CONCLUSIONS AND RELEVANCE Spontaneous improvement of visual acuity in patients with G11778A LHON is not common and is partial and limited when it occurs, so improvements in vision with adeno-associated virus-mediated gene therapy of a synthetic wild-type ND4 subunit gene should be possible to detect with a reasonable sample size. Visual acuity appears to be the most suitable primary end point for the planned clinical trial." @default.
- W2054303973 created "2016-06-24" @default.
- W2054303973 creator A5002103816 @default.
- W2054303973 creator A5006087398 @default.
- W2054303973 creator A5012602381 @default.
- W2054303973 creator A5030704924 @default.
- W2054303973 creator A5038475617 @default.
- W2054303973 creator A5059567653 @default.
- W2054303973 creator A5084191707 @default.
- W2054303973 creator A5086342594 @default.
- W2054303973 date "2014-04-01" @default.
- W2054303973 modified "2023-09-27" @default.
- W2054303973 title "Trial End Points and Natural History in Patients With G11778A Leber Hereditary Optic Neuropathy" @default.
- W2054303973 cites W1969621923 @default.
- W2054303973 cites W1971920327 @default.
- W2054303973 cites W1978644403 @default.
- W2054303973 cites W1998545339 @default.
- W2054303973 cites W2010162962 @default.
- W2054303973 cites W2032229012 @default.
- W2054303973 cites W2045900081 @default.
- W2054303973 cites W2046631819 @default.
- W2054303973 cites W2050871070 @default.
- W2054303973 cites W2060065962 @default.
- W2054303973 cites W2062772019 @default.
- W2054303973 cites W2070864958 @default.
- W2054303973 cites W2071888455 @default.
- W2054303973 cites W2075745212 @default.
- W2054303973 cites W2087071251 @default.
- W2054303973 cites W2088839544 @default.
- W2054303973 cites W2089263532 @default.
- W2054303973 cites W2094696217 @default.
- W2054303973 cites W2106453714 @default.
- W2054303973 cites W2107031757 @default.
- W2054303973 cites W2112785879 @default.
- W2054303973 cites W2124154990 @default.
- W2054303973 cites W2124168907 @default.
- W2054303973 cites W2126877711 @default.
- W2054303973 cites W2146076174 @default.
- W2054303973 cites W2152856466 @default.
- W2054303973 cites W2155767671 @default.
- W2054303973 cites W2157584077 @default.
- W2054303973 cites W2168763081 @default.
- W2054303973 cites W99108903 @default.
- W2054303973 cites W2615749116 @default.
- W2054303973 doi "https://doi.org/10.1001/jamaophthalmol.2013.7971" @default.
- W2054303973 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4266137" @default.
- W2054303973 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24525545" @default.
- W2054303973 hasPublicationYear "2014" @default.
- W2054303973 type Work @default.
- W2054303973 sameAs 2054303973 @default.
- W2054303973 citedByCount "76" @default.
- W2054303973 countsByYear W20543039732015 @default.
- W2054303973 countsByYear W20543039732016 @default.
- W2054303973 countsByYear W20543039732017 @default.
- W2054303973 countsByYear W20543039732018 @default.
- W2054303973 countsByYear W20543039732019 @default.
- W2054303973 countsByYear W20543039732020 @default.
- W2054303973 countsByYear W20543039732021 @default.
- W2054303973 countsByYear W20543039732022 @default.
- W2054303973 countsByYear W20543039732023 @default.
- W2054303973 crossrefType "journal-article" @default.
- W2054303973 hasAuthorship W2054303973A5002103816 @default.
- W2054303973 hasAuthorship W2054303973A5006087398 @default.
- W2054303973 hasAuthorship W2054303973A5012602381 @default.
- W2054303973 hasAuthorship W2054303973A5030704924 @default.
- W2054303973 hasAuthorship W2054303973A5038475617 @default.
- W2054303973 hasAuthorship W2054303973A5059567653 @default.
- W2054303973 hasAuthorship W2054303973A5084191707 @default.
- W2054303973 hasAuthorship W2054303973A5086342594 @default.
- W2054303973 hasBestOaLocation W20543039731 @default.
- W2054303973 hasConcept C118487528 @default.
- W2054303973 hasConcept C126322002 @default.
- W2054303973 hasConcept C142724271 @default.
- W2054303973 hasConcept C163276114 @default.
- W2054303973 hasConcept C187212893 @default.
- W2054303973 hasConcept C2776058522 @default.
- W2054303973 hasConcept C2776135927 @default.
- W2054303973 hasConcept C2777056713 @default.
- W2054303973 hasConcept C2778233873 @default.
- W2054303973 hasConcept C2778257484 @default.
- W2054303973 hasConcept C2780592520 @default.
- W2054303973 hasConcept C2780837183 @default.
- W2054303973 hasConcept C512399662 @default.
- W2054303973 hasConcept C535046627 @default.
- W2054303973 hasConcept C71924100 @default.
- W2054303973 hasConceptScore W2054303973C118487528 @default.
- W2054303973 hasConceptScore W2054303973C126322002 @default.
- W2054303973 hasConceptScore W2054303973C142724271 @default.
- W2054303973 hasConceptScore W2054303973C163276114 @default.
- W2054303973 hasConceptScore W2054303973C187212893 @default.
- W2054303973 hasConceptScore W2054303973C2776058522 @default.
- W2054303973 hasConceptScore W2054303973C2776135927 @default.
- W2054303973 hasConceptScore W2054303973C2777056713 @default.
- W2054303973 hasConceptScore W2054303973C2778233873 @default.
- W2054303973 hasConceptScore W2054303973C2778257484 @default.
- W2054303973 hasConceptScore W2054303973C2780592520 @default.
- W2054303973 hasConceptScore W2054303973C2780837183 @default.
- W2054303973 hasConceptScore W2054303973C512399662 @default.